Martingale Asset Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,995
| Closed | -$384K | – | 771 |
|
|
2024
Q4 | $384K | Hold |
28,995
| – | – | 0.01% | 647 |
|
|
2024
Q3 | $971K | Buy |
28,995
+360
| +1% | +$12.1K | 0.02% | 461 |
|
|
2024
Q2 | $718K | Hold |
28,635
| – | – | 0.02% | 523 |
|
|
2024
Q1 | $645K | Buy |
28,635
+16
| +0.1% | +$360 | 0.01% | 564 |
|
|
2023
Q4 | $613K | Hold |
28,619
| – | – | 0.01% | 560 |
|
|
2023
Q3 | $514K | Hold |
28,619
| – | – | 0.01% | 607 |
|
|
2023
Q2 | $582K | Buy |
28,619
+1,702
| +6% | +$34.6K | 0.01% | 583 |
|
|
2023
Q1 | $586K | Buy |
26,917
+800
| +3% | +$17.4K | 0.01% | 582 |
|
|
2022
Q4 | $809K | Buy |
26,117
+7
| +0% | +$217 | 0.02% | 518 |
|
|
2022
Q3 | $667K | Buy |
26,110
+2,500
| +11% | +$63.9K | 0.01% | 551 |
|
|
2022
Q2 | $480K | Buy |
23,610
+1,101
| +5% | +$22.4K | 0.01% | 648 |
|
|
2022
Q1 | $558K | Sell |
22,509
-2,700
| -11% | -$66.9K | 0.01% | 618 |
|
|
2021
Q4 | $877K | Sell |
25,209
-8,305
| -25% | -$289K | 0.01% | 529 |
|
|
2021
Q3 | $910K | Buy |
33,514
+13,800
| +70% | +$375K | 0.01% | 529 |
|
|
2021
Q2 | $512K | Buy |
19,714
+1,701
| +9% | +$44.2K | 0.01% | 585 |
|
|
2021
Q1 | $390K | Buy |
18,013
+5,197
| +41% | +$113K | ﹤0.01% | 680 |
|
|
2020
Q4 | $276K | Sell |
12,816
-4,802
| -27% | -$103K | ﹤0.01% | 759 |
|
|
2020
Q3 | $260K | Hold |
17,618
| – | – | ﹤0.01% | 933 |
|
|
2020
Q2 | $394K | Buy |
17,618
+297
| +2% | +$6.64K | ﹤0.01% | 913 |
|
|
2020
Q1 | $245K | Sell |
17,321
-1,091
| -6% | -$15.4K | ﹤0.01% | 905 |
|
|
2019
Q4 | $300K | Buy |
+18,412
| New | +$300K | ﹤0.01% | 920 |
|